Discovery of (+)-N-(3-Aminopropyl)-N-[1-(5-benzyl-3-metlyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-metlylpropyl]-4-methylbenzamide (AZD4877), a Kinesin Spindle Protein Inhibitor and Potential Anticancer Agent

被引：40

作者：

Theoclitou, Maria-Elena ^{[1
]}

Aquila, Brian ^{[2
]}

Block, Michael H. ^{[2
]}

Brassil, Patrick J. ^{[2
]}

Castriotta, Lillian ^{[2
]}

Code, Erin ^{[2
]}

Collins, Michael P. ^{[2
]}

Davies, Audrey M. ^{[2
]}

Deegan, Tracy ^{[2
]}

Ezhuthachan, Jayachandran ^{[2
,3
]}

Filla, Sandra ^{[2
,3
]}

Freed, Ellen ^{[2
,3
]}

Hu, Haiqing ^{[2
]}

Huszar, Dennis ^{[2
]}

Jayaraman, Muthusamy

Lawson, Deborah ^{[2
]}

Lewis, Paula M. ^{[2
]}

Nadella, Murali V. P. ^{[2
]}

Oza, Vibha ^{[2
]}

Padmanilayam, Maniyan ^{[4
]}

Pontz, Timothy ^{[2
]}

Ronco, Lucienne ^{[2
,3
]}

Russell, Daniel ^{[2
]}

Whitston, David ^{[2
]}

Zheng, Xiaolan ^{[2
]}

机构：

[1] AstraZeneca, Canc & Infect Res Area, Macclesfield SK10 4TG, Cheshire, England

[2] AstraZeneca R&D Boston, Canc & Infect Res Area, Waltham, MA 02451 USA

[3] AstraZeneca Boston, Boston, MA USA

[4] Organix Inc, Woburn, MA 01801 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2011年 / 54卷 / 19期

关键词：

MITOTIC MOTOR PROTEIN; ANTIMITOTIC DRUG; EG5; MICROTUBULES; MECHANISMS; RESISTANCE; CANCER; TAXOL; KSP; BIPOLARITY;

D O I：

10.1021/jm200629m

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Structure activity relationship analysis identified (+)-N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), from a series of novel kinesin spindle protein (KSP) inhibitors, as exhibiting both excellent biochemical potency and pharmaceutical properties suitable for clinical development. The selected compound arrested cells in mitosis leading to the formation of the monopolar spindle phenotype characteristic of KSP inhibition and induction of cellular death. A favorable pharmacokinetic profile and notable in vivo efficacy supported the selection of this compound as a clinical candidate for the treatment of cancer.

引用

页码：6734 / 6750

页数：17

共 50 条

[41] Design, molecular modelling, synthesis, characterization studies of novel N-(7-(substituted benzylidene)-4-phenyl-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-2-yl)-1-(substituted phenyl)methanimine against breast cancer
Manoharan, Arunkumar
Theivendren, Panneerselvam
Sharma, Maya
Kunjiappan, Selvaraj
Govindaraj, Saravanan
Pavadai, Parasuraman
JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2025, : 561 - 573
[42] Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl) piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine
Jiang, Xueyang
Liu, Chang
Zou, Manxing
Xie, Huanfang
Lin, Tailiang
Lyu, Weiping
Xu, Jian
Li, Yuan
Feng, Feng
Sun, Haopeng
Liu, Wenyuan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 223
[43] SYNTHESIS OF A NOVEL 5-DEAZA-5-THIA ANALOG OF TETRAHYDROFOLIC ACID, N-(P-([(2-AMINO-6,7-DIHYDRO-4-OXO-3H,8H-PYRIMIDO[5,4-B][1,4]THIAZIN-6-YL)METHYL]AMINO)BENZOYL)GLUTAMIC ACID
TOTANI, R
SAKE, M
HIROTA, K
MAKI, Y
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1994, (07): : 833 - 836
[44] Discovery of (R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153):: A potent antagonist of the human calcitonin gene-related peptide receptor for migraine with rapid and efficient intranasal exposure
Degnan, Andrew P.
Chaturvedula, Prasad V.
Conway, Charles M.
Cook, Deborah A.
Davis, Carl D.
Denton, Rex
Han, Xiaojun
Macci, Robert
Mathias, Neil R.
Moench, Paul
Pin, Sokhoin S.
Ren, Shelly X.
Schartman, Richard
Signor, Laura J.
Thalody, George
Widmann, Kimberly A.
Xu, Cen
Macor, John E.
Dubowchik, Gene M.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) : 4858 - 4861
[45] Selectivity of N-Aroyl-N′-arylthioureas towards 2-(1,3-Dioxo-1H-inden-2(3H)-ylidene)malononitrile. New Synthesis of (Z)-N-((E)-4-Amino-1-aryl-5-cyano-6-oxo-1H-indeno[1,2-d][1,3]-thiazepin-2(6H)-ylidene)-4-arylamides of Antitumor and Antioxidant Activities
Aly, Ashraf A.
Brown, Alan B.
Ramadan, Mohamed
Abdel-Aziz, Mohamed
Abuo-Rahma, Gamal El-Din A. A.
Radwan, Mohamed F.
Gamal-Eldeen, Amira M.
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2010, 47 (03) : 503 - 508
[46] Discovery of N-[2-[5-[amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylglycine (ZK-807834):: A potent, selective, and orally active inhibitor of the blood coagulation enzyme factor Xa
Phillips, GB
Buckman, BO
Davey, DD
Eagen, KA
Guilford, WJ
Hinchman, J
Ho, E
Koovakkat, S
Liang, A
Light, DR
Mohan, R
Ng, HP
Post, JM
Shaw, KJ
Smith, D
Subramanyam, B
Sullivan, ME
Trinh, L
Vergona, R
Walters, J
White, K
Whitlow, M
Wu, S
Xu, W
Morrissey, MM
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (19) : 3557 - 3562
[47] Identification by molecular dynamic simulation and in vitro validation of SISB-A1, N-[1-(4-bromophenyl)-3-methyl-1H-pyrazol-5-yl]-2-[(2-oxo-4-phenyl-2H-chromen-7-yl) oxy], as an inhibitor of the AblT315I mutant kinase to combat imatinib resistance in chronic myeloid leukemia
Mesfer Al Shahrani
Reem M. Gahtani
Mohammad Abohassan
Sultan Alasmari
Mohammed Makkawi
Medical Oncology, 40
[48] Identification by molecular dynamic simulation and in vitro validation of SISB-A1, N-[1-(4-bromophenyl)-3-methyl-1H-pyrazol-5-yl]-2-[(2-oxo-4-phenyl-2H-chromen-7-yl) oxy], as an inhibitor of the AblT315I mutant kinase to combat imatinib resistance in chronic myeloid leukemia
Al Shahrani, Mesfer
Gahtani, Reem M.
Abohassan, Mohammad
Alasmari, Sultan
Makkawi, Mohammed
MEDICAL ONCOLOGY, 2023, 40 (11)
[49] The Discovery of N-((2H-Tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): A Potent and Selective Glucagon Receptor Antagonist
DeMong, Duane
Dai, Xing
Hwa, Joyce
Miller, Michael
Lin, Sue-Ing
Kang, Ling
Stamford, Andrew
Greenlee, William
Yu, Wensheng
Wong, Michael
Lavey, Brian
Kozlowski, Joseph
Zhou, Guowei
Yang, De-Yi
Patel, Bhuneshwari
Soriano, Aileen
Zhai, Ying
Sondey, Christopher
Zhang, Hongtao
Lachowicz, Jean
Grotz, Diane
Cox, Kathleen
Morrison, Richard
Andreani, Teresa
Cao, Yang
Liang, Mark
Meng, Tao
McNamara, Paul
Wong, Jesse
Bradley, Prudence
Feng, Kung-I
Belani, Jitendra
Chen, Ping
Dai, Peng
Gauuan, Jolicia
Lin, Peishan
Zhao, He
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2601 - 2610
[50] Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl) phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor
Liang, Qianmao
Chen, Yongfei
Yu, Kailin
Chen, Cheng
Zhang, Shouxiang
Wang, Aoli
Wang, Wei
Wu, Hong
Liu, Xiaochuan
Wang, Beilei
Wang, Li
Hu, Zhenquan
Wang, Wenchao
Ren, Tao
Zhang, Shanchun
Liu, Qingsong
Yun, Cai-Hong
Liu, Jing
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 131 : 107 - 125

← 1 2 3 4 5 →